Media Partners

Our Media Partners

Take a look at the media partners who decided to support the 16^th World ADC London. If you are interested in a media partnership, please contact info@hansonwade.com.

ADC Directory

Learn more:

The ADC Directory (adcdirectory.com) is an online resource platform and community for professionals in the
Antibody-Drug Conjugate (ADC) field, serving as a companion to ADC Review | Journal of Antibody-Drug Conjugates. The ADC Directory offers a comprehensive, member-driven resource for businesses and professionals alike, including an information exchange, networking opportunities, and a showcase of industry news, events, products, and career opportunities for researchers, developers, and manufacturers. It's a resource for discovering solutions, sharing expertise, and connecting businesses within the growing world of targeted cancer therapies. Search by solution or service, compare reviews, and connect with fellow members.

Special discount AFTER signing up for World ADC London 2026

Finally, please note that any new sign-ups for the Business Listing or Professional Listing in the ADC Directory (using code: WorldADCLondon2026) will receive a 25% discount on registration costs for 2026.

www.adcdirectory.com

ADC Review

Learn more:

ADC Review | Journal of Antibody-drug Conjugates (www.adcreview.com), launched in 2013, is the primary online journal and resource for news, articles, and peer-reviewed content on the research, development, and clinical application of Antibody-drug Conjugates, BiSpecific ADCs, Site-Specific ADC, Small Molecule Drug Conjugates (SMDC), Engineered Antibody Fragments, Novel Format Conjugates, nano-ADC-like Targeted Nanospheres (nADC/TNS), and related targeted cancer therapies. The journal is designed to serve the needs of a diverse community of academia, life sciences, pharma, (basic, translational, and clinical) research, clinicians/physicians, along with regulatory affairs, government authorities, and representatives from payers, and policy makers. The purpose of the Journal is to present scientific and clinical information in an understandable and useful format for all stakeholders. Manuscripts can be submitted via the submission website https://jadc.manuscriptmanager.net/

Antibody Society, Media Partner at 16th World ADC London Summit

Antibody Society (TAbS)

Learn more:

The Antibody Society (TAbS) is an international non-profit organization that unites a global community of over 3,000 scientists across 25 countries who are advancing antibody research and development. We are supported by more than 50 sponsors and partners from the Biotech, Pharma, CRO, and CDMO sectors.

The mission of The Antibody Society (TAbS) is to provide an international forum across all career levels for the field of recombinant antibodies, antibody and T-cell receptor engineering, computational systems immunology and related areas.

We work with academia and industry to create resources in antibody R&D through webinars, newsletters, podcasts, scientific publications, and our Antibody Therapeutics database (YAbS), which features nearly 3,000 antibody therapeutics, from preclinical to recently approved.

As a scientific program partner to antibody-related conferences worldwide, we provide poster presentation opportunities for early career scientists who have made significant contributions to the field. We also host competitions that recognize and spotlight the research of graduate students and postdocs to the broader scientific community. The AIRR Community (AIRR-C), part of TAbS, advances standards for antibody and T-cell receptor data. The AIRR community's Data Commons platform, provides public access to more than 80 MiAIRR compliant datasets, advancing transparency and collaboration in immune repertoire research.

Our vision is to be the go-to organization for antibody enthusiasts, enabling them to feel scientifically inspired, acquire trustworthy business intelligence, and find support for global community interactions.

Upcoming news: We are hosting a webinar with Sanofi on January 28th at 12 PM ET. Join us to learn more about SNAC-DB: A New Open-Source Resource for Antibody & NANOBODY® VHH–Antigen Modeling.
Learn more & register here.

Bioconjugate Insights

Learn more:

An online, open access, peer-reviewed journal with an interdisciplinary, translational focus on all aspects and areas of the bioconjugation field. Bioconjugate Insights provides a unique platform for the bioconjugation community’s experts to explore key current trends, challenges, and breakthroughs. Core areas for coverage include, but are not limited to:

ADCs
Antibody-oligonucleotide conjugates (AOCs)
Bispecific ADCs (BsADCs)
Conjugated vaccines
Diagnostic and imaging tools
Enzyme conjugates
Nanoparticle conjugates
Polymer conjugates – including PEGylation
Protein and peptide conjugates (PPCs)
Radioconjugates
Targeted drug delivery
Theranostics

A blend of in-depth scientific and technical detail with ‘big picture’ strategic analysis provides the perfect platform to contextualize recent progress, address current issues, and share insight into future directions for this rapidly developing sector.

Additionally, Bioconjugate Insights' comprehensive scope and coverage spans engineering and design, manufacturing and supply chain, preclinical and clinical R&D, regulation, financing, market access, and more.

It is the first and only dedicated digital content channel specifically designed to keep industry and academic professionals up to date with this truly global sector’s evolution on a genuinely worldwide scale.

www.bioconjugate-insights.com.

BioPharma Asia

Learn more:

BioPharma Asia aims to keep its readers abreast of all developments in Manufacturing, Development, Quality Assurance, Outsourcing and Regulatory Affairs, with only the highest quality articles and webinars written and presented by the most respected authors/presenters associated with only end-user companies. So, ensuring the information will always be guaranteed to remain timely, informative, and unbiased.

www.biopharma-asia.com

The Chemical Data

Learn more:

Chinese Antibody Society - Media Partner at 16th World ADC London

Chinese Antibody Society (ChAbS)

Learn more:

Founded in April 2016, the Chinese Antibody Society (ChAbS) is a nonprofit, non-governmental, international, and professional organization with the focus on antibody-based therapeutics. It was registered in the Commonwealth of Massachusetts of the United States.

The mission of ChAbS is to build up a community to bring together industry, academia, healthcare providers, and investors to connect, communicate, and collaborate on the discovery, development, manufacturing, and commercialization of therapeutic antibodies.

Antibody Therapeutics is the official journal of ChAbS, published by Oxford University Press. As an international peer-reviewed open access journal, Antibody Therapeutics provides a forum for the publication of the latest advances and challenges in the discovery, research, development, manufacturing, and methodology of therapeutic antibodies for the global scientific community. Antibody Therapeutics is indexed by ESCI, PubMed and Scopus with a CiteScore™ (Scopus) of 8.4, a first Impact Factor of 4.5 (Journal Citation Reports™), and over 175,000 full-text downloads in 2024.

www.academic.oup.com/abt

European Biotechnology Magazine

Learn more:

Life Sciences Review

Learn more:

Life Science Review Magazine is a print and digital magazine with a total subscription of 124,000 qualified subscribers consisting of senior decision-makers from Pharmaceutical, Biotech, Medical Device and Diagnostic space performing functions in Sales & Marketing, Manufacturing, Supply Chain, R&D, Clinical Operations, Finance, and HR. It provides a comprehensive platform for senior-level industry experts, acquirers, and decision-makers to share their insights following a unique peer learning approach.

www.lifesciencesreview.com

MabDesign

Learn more:

Mabdesign is an association that provides scientific, technological, and business expertise in biotherapies and bioproduction, for the benefit of drug developers as well as service providers. Founded in 2014, self-financed and strong of over 360 French and European members, the MabDesign association is committed to being the leading expert resource for stakeholders in this highly innovative field.

With this aim, our science-oriented team proposes conferences, trainings courses and publications to disseminate innovations, along with business services to support the marketing, business development and non-dilutive financing to promote innovation.

More information: www.mabdesign.fr/en/

OncoDaily

Learn more:

OncoDaily is the leading oncology media platform globally and the largest news channel in medicine, publishing approximately 100 news articles every day. It brings together a worldwide community of cancer professionals, patients, advocates, and organizations. Its vision is to be the fastest, most reliable, and most innovative global source of oncology information—where every voice has a space to shape the future of cancer care.

www.oncodaily.com

Oncology News Today

Learn more:

Oncology News Today is an authoritative and easy to access resource for oncology healthcare professionals, providing news and information to support oncology care throughout the UK.

Launched in Summer 2022, Oncology News Today is a ‘one stop shop’ for all things oncology and is proud to work with a number of leading oncology organisations.

Oncology News Today shares the latest news, jobs, events and On Air podcast episodes across its social media platforms and through its free monthly newsletter and runs educational webinars.

www.oncologynewstoday.co.uk

Pharma Focus Europe

Learn more:

Pharma Focus Europe, a pivotal B2B global digital publication, is the go-to resource for pharmaceutical professionals navigating the dynamic European market. Committed to delivering real-time insights, our platform provides a nuanced perspective on industry trends, regulatory shifts, and groundbreaking innovations. Through thought-provoking analyses, exclusive interviews, and timely news, Pharma Focus Europe empowers industry leaders to make informed decisions and stay ahead in the rapidly evolving pharmaceutical landscape. Join our community of experts and executives, where knowledge converges with opportunity, shaping the future of healthcare across Europe. Pharma Focus Europe is your indispensable guide to success in the pharmaceutical arena.

www.pharmafocuseurope.com

PHARMAnetwork

Learn more:

PHARMAnetwork magazine covers, every aspect of pharmaceutical value chain, the change and developments in the intersection between pharmaceutical industry and outsourcing industry. We perform interviews and write articles whose thematic strategies, organizations, mergers and acquisitions, regulatory, innovation in the pharmaceutical development and contract manufacturing.

www.pharmanetwork.digital

Explore the Agenda

Hear the latest industry insights and discover cutting-edge, end-to-end ADC content from early discovery to late-stage manufacturing.

View Presentations & Speakers

Partner With Us

Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma deals.

Explore Sponsorship Options

Join Biopharma Experts

Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.

Media Partners

Our Media Partners

ADC Directory

ADC Review

Antibody Society (TAbS)

Bioconjugate Insights

BioPharma Asia

The Chemical Data

Chinese Antibody Society (ChAbS)

European Biotechnology Magazine

Life Sciences Review

MabDesign

OncoDaily

Oncology News Today

Pharma Focus Europe

PHARMAnetwork

Explore the Agenda

Partner With Us

Join Biopharma Experts

Venue

Map

Contact

Join Our Team

About Us

Explore Our Products

Stay Connected

Search

Organised By